Overgaard, Katrine Schultz http://orcid.org/0000-0003-4445-8235
Mohamed, Roda Abdulkadir http://orcid.org/0000-0003-0003-4801
Andersen, Thomas Rueskov http://orcid.org/0000-0003-0251-4489
Lambrechtsen, Jess http://orcid.org/0000-0002-9976-9981
Egstrup, Kenneth http://orcid.org/0000-0002-6214-8751
Auscher, Søren http://orcid.org/0000-0003-0399-2503
Clinical trials referenced in this document:
Documents that mention this clinical trial
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial
https://doi.org/10.1186/s12933-024-02340-w
Article History
Received: 29 May 2024
Accepted: 26 June 2024
First Online: 8 July 2024
Declarations
:
: The study was approved by the Ethical committee of the Region of Southern Denmark in May 2023 (Project-ID: S-20230015). Informed consent is obtained from all participants before study-specific procedures begin.
: Not applicable.
: The authors declare that they have no competing interests.